Vol 66, No 6 (2008)
Other
Published online: 2008-06-23
Evidence-based cardiology
Ramipryl i telmisartan podobnie skutecznie zapobiegają incydentom wieńcowym – wyniki badania ONTARGET. Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59.
DOI: 10.33963/v.kp.80523
Kardiol Pol 2008;66(6):705-706.
Abstract
Not available